Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids

Neurodegeneration of the brain after ischemia is a major cause of severe, long-term disability, dementia, and mortality, which is a global problem. These phenomena are attributed to excitotoxicity, changes in the blood–brain barrier, neuroinflammation, oxidative stress, vasoconstriction, cerebral am...

Full description

Bibliographic Details
Published in:	Molecules
Main Authors:	Ryszard Pluta, Barbara Miziak, Stanisław J. Czuczwar
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	brain ischemia Alzheimer’s disease proteinopathy apitherapy honey excitotoxicity neuroinflammation
Online Access:	https://www.mdpi.com/1420-3049/28/15/5624

Similar Items

The Therapeutic Potential of Apitherapy: A Comprehensive Review on the Health Benefits of Honey and Propolis
by: Katarzyna Żak, et al.
Published: (2025-04-01)

Overview of Apitherapy Products: Anti-Cancer Effects of Bee Venom Used in Apitherapy
by: Hüsamettin Vatansev, et al.
Published: (2021-04-01)

Historical aspect as a fundamental importance apitherapy, time and place of this integrative healing methods in traditional medicine
by: Đorđević Nataša
Published: (2016-01-01)

Utilization of apitherapy in allergic asthma: A systematic review of clinical and preclinical studies
by: Nicolas Daniel Widjanarko, et al.
Published: (2024-09-01)

Influence of altitudinal variation on the total phenolic and flavonoid content of Acacia and Ziziphus honey
by: Mohamed H. A. Suleiman, et al.
Published: (2020-01-01)

Towards a Better Understanding of Nutritional and Therapeutic Effects of Honey and Their Applications in Apitherapy
by: Alexandra-Antonia Cucu, et al.
Published: (2021-05-01)

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type
by: Ryszard Pluta, et al.
Published: (2021-08-01)

A Review of Commonly Used Methodologies for Assessing the Antibacterial Activity of Honey and Honey Products
by: Md Lokman Hossain, et al.
Published: (2022-07-01)

The Relationship Between The Use of Apitherapy Products and The Frequency of Constipation in Adults
by: Semra Türkoğlu, et al.
Published: (2025-04-01)

Comparative Study of Antimicrobial Properties of Bee Venom Extracts and Melittins of Honey Bees
by: Jakkrawut Maitip, et al.
Published: (2021-12-01)

Mechanism of apitherapy in preventing and treating Alzheimer's disease: A bibliometric analysis
by: Huaneng Wen, et al.
Published: (2025-03-01)

Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy
by: Ryszard Pluta, et al.
Published: (2022-01-01)

Potential of apitherapy in the management of cardiovascular diseases
by: Rimpa Karmakar, et al.
Published: (2025-04-01)

Apitherapy and Periodontal Disease: Insights into In Vitro, In Vivo, and Clinical Studies
by: Manoj Kumar, et al.
Published: (2022-04-01)

Royal‐jelly‐based apitherapy can attenuate damages to male reproductive parameter following nicotine administration
by: Mahsa Nazar‐Zadeh, et al.
Published: (2022-04-01)

Effect of Apitherapy Formulations against Carbon Tetrachloride-Induced Toxicity in Wistar Rats after Three Weeks of Treatment
by: Calin Vasile Andritoiu, et al.
Published: (2014-08-01)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
by: Barbara Vuic, et al.
Published: (2022-11-01)

Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration
by: Amit Shrestha, et al.
Published: (2015-11-01)

Awareness of Apitherapy: a study of healthcare professionals in Tμrkiye
by: İҫim Gökkaya, et al.
Published: (2025-03-01)

Study of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling
by: Yulia V. Stepenko, et al.
Published: (2024-06-01)

Evaluation of Knowledge and Opinions on Apitherapy Products among 1st and 4th Year Nutrition and Dietetics Department Students
by: Ayfer Beyaz Coşkun, et al.
Published: (2024-12-01)

Study of specific pharmacological activity of standardized composition of bee product substances for treatment of urogenital system
by: V. M. Koval, et al.
Published: (2017-10-01)

Apitherapy for Age-Related Skeletal Muscle Dysfunction (Sarcopenia): A Review on the Effects of Royal Jelly, Propolis, and Bee Pollen
by: Amira Mohammed Ali, et al.
Published: (2020-09-01)

Bee products: An overview of sources, biological activities and advanced approaches used in apitherapy application
by: Samia E. El-Didamony, et al.
Published: (2024-12-01)

Validity and Reliability of Clinical and Patient‐Reported Outcomes in Multisystem Proteinopathy 1
by: Lindsay N. Alfano, et al.
Published: (2025-07-01)

A Prospective Viewpoint on Neurological Diseases and Their Biomarkers
by: Mehrukh Zehravi, et al.
Published: (2022-05-01)

Peripheral proteinopathy in neurodegenerative diseases
by: Bin Xu, et al.
Published: (2025-01-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
by: Albert Acewicz, et al.
Published: (2023-07-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 1
by: Albert Acewicz, et al.
Published: (2022-11-01)

Assessment of antibacterial potential of Natural and Commercial Honey samples against Wound Isolates
by: Zareen Fatima, et al.
Published: (2020-09-01)

Effect of Lingnan Painless Apitherapy combined with McKenzie Therapy on Patients with Lumbar Disc Herniation
by: Hongbo WU, et al.
Published: (2020-12-01)

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
by: Chantal B. Lucini, et al.
Published: (2021-04-01)

The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?
by: Lynette M. Bustos, et al.
Published: (2023-02-01)

Persistent Neurovascular Unit Dysfunction: Pathophysiological Substrate and Trigger for Late-Onset Neurodegeneration After Traumatic Brain Injury
by: Yunxiang Zhou, et al.
Published: (2020-06-01)

Development and In Vitro Characterization of [<sup>3</sup>H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies
by: Andrea Varrone, et al.
Published: (2025-06-01)

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
by: Chanchal Sharma, et al.
Published: (2021-07-01)

Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration
by: Ryszard Pluta
Published: (2025-10-01)

Ferulic acid ameliorates neurodegeneration via the Nrf2/ARE signalling pathway: A Review
by: Surbhi Singh, et al.
Published: (2022-12-01)

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01)